IPO Definitive Healthcare

Definitive Healthcare provides healthcare commercial intelligence through its cloud-based platform. Over 2,600 customers optimize their business processes by using the company’s intelligence. Medium risk. Expected return – up to 40%.

Aided by an AI engine, the company gathers data on a daily basis on everything ranging from new partnerships to bills and tech initiatives and aggregates it in its cloud-based platform.

The global market for healthcare analytics is estimated to reach $46 billion by 2027. The Definitive Healthcare platform is used by biopharmaceutical, biotechnology, and medical device companies. The company estimates its total addressable market at $10 billion. It counts Allergan, Siemens, Amazon, GE Healthcare, TherapeuticsMD as clients.

Definitive Healthcare will list its common stock under the ticker “DH” on the Nasdaq exchange. Its value at IPO will approximate around $3.5 billion. Goldman Sachs, J.P. Morgan, Morgan Stanley, Barclays, Credit Suisse, and Deutsche Bank are acting as underwriters. According to our estimates, the value of the company in the public market can reach $4–5 billion.

You can apply for this investment until September 13, 19:00 UTC+3.